CMHC 2014 Symposium: The Triglycerides Conundrum

This activity addresses current controversies in triglyceride management with the goal of providing the insight, strategies, and practical guidance to effectively manage persistently elevated triglycerides in patients who remain at high CV risk.

Supported by an educational grant from Amarin Pharma, Inc.

Opening Remarks

Chairperson: Harold E. Bays, MD

The Relationship of Triglycerides to Cardiovascular Disease: To Treat or Not To Treat?

Faculty: Christie M. Ballantyne, MD

Lifestyle Matters: What's the Real Role of Nutritional and Lifestyle Interventions in Hypertriglyceridemia Management?

Faculty: Harold E. Bays, MD

Reducing Triglyceride Levels in At-Risk Patients: What Are Clinicians to Do?

Faculty: Eliot A. Brinton, MD

Expert Opinion and Best Practices for Managing Triglycerides and Residual CV Risk: Interactive, Case-Based Scenarios, Panel Discussion and Debate along with Audience Q&A

Moderator: Harold E. Bays, MD

Discussants: Eliot A. Brinton, MDChristie M. Ballantyne, MD